Diabetic retinopathy is associated with decreased tyrosine nitrosylation of vitreous interleukins IL-1α, IL-1β, and IL-7

Ophthalmic Research

Volumn 46, Issue 4, 2011, Pages 169-174

  Reverter, Jordi L ^a   Nadal, Jeroni ^b   Ballester, Joan ^c   Ramió Lluch, Laura ^c   Rivera, M Montserrat ^c   Fernández Novell, Josep M ^d   Elizalde, Javier ^b   Abengoechea, Santiago ^b   Rodriguez, Joan Enrique ^c  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b INSTITUT UNIVERSITARI BARRAQUER   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Diabetic retinopathy; Tyrosine nitrosylation; Vitreous interleukins

Indexed keywords

ACETYLSALICYLIC ACID; INSULIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 7; RAMIPRIL; SIMVASTATIN; TYROSINE; 3-NITROTYROSINE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; IL7 PROTEIN, HUMAN; NITRIC OXIDE; PHOSPHOTYROSINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; IMMUNOPRECIPITATION; MALE; NITROSYLATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VITRECTOMY; VITREOUS BODY; AGED; ANALOGS AND DERIVATIVES; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; MIDDLE AGED; PHOSPHORYLATION; WESTERN BLOTTING;

AGED; BLOOD GLUCOSE; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOPRECIPITATION; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; INTERLEUKIN-7; MALE; MIDDLE AGED; NITRIC OXIDE; PHOSPHORYLATION; PHOSPHOTYROSINE; TYROSINE; VITREOUS BODY;

EID: 79953065892     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000323812     Document Type: Article

References (32)

1. Frank RN: Diabetic retinopathy: N Engl J Med 2004; 350: 48-58.
2. Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN, DCCT/EDIC Research Group: Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial-revisited. Diabetes 2008; 57: 995-1001.
3. Goldberg RB: Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 2009; 94: 3171-3182.
4. Kern TS: Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007; 2007: 95103.
5. Funatsu H, Noma H, Mimura T, Eguchi S, Hori S: Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology 2009; 116: 73-79.
6. Reverter JL, Nadal J, Fernández-Novell JM, et al.: Tyrosine phosphorylation of vitreous inflammatory and angiogenic peptides and proteins in diabetic retinopathy. Invest Ophthalmol Vis Sci 2009; 50: 1378-1382.
7. Yeo WS, Lee SJ, Lee JR, Kim KP: Nitrosative protein tyrosine modifications: biochemistry and functional significance. BMB Rep 2008; 41: 194-203.
8. Ischiropoulos H: Biological tyrosine nitrosylation: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998; 356: 1-11.
9. Turko IV, Murad F: Protein nitrosylation in cardiovascular diseases. Pharmacol Rev 2002; 54: 619-634.
10. Piconi L, Quagliaro L, Ceriello A: Oxidative stress in diabetes. Clin Chem Lab Med 2003; 41: 1144-1149. (Pubitemid 37265692)
11. Silva KC, Rosales MA, Biswas SK, Lopes de Faria JB, Lopes de Faria JM: Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes. Diabetes 2009; 58: 1382-1390.
12. Zhan X, Du Y, Crabb JS, Gu X, Kern TS, Crabb JW: Targets of tyrosine nitrosylation in diabetic rat retina. Mol Cell Proteomics 2008; 7: 864-874. (Pubitemid 351737088)
13. Du Y, Sarthy VP, Kern TS: Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. Am J Physiol Regul Integr Comp Physiol 2004; 287:R735-R741. (Pubitemid 39280457)
14. Du Y, Miller CM, Kern TS: Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 2003; 35: 1491-1499. (Pubitemid 37452474)
15. Mohamed Q, Gillies MC, Wong TY: Management of diabetic retinopathy: a systematic review. JAMA 2007; 298: 902-916. (Pubitemid 47311296)
16. American Diabetes Association: Diagnosis and classification of diabetes mellitus (Position Statement): Diabetes Care 2007; 30 (suppl 1):S42-S47.
17. Joussen AM, Poulaki V, Le ML, et al.: A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004; 18: 1450-1452. (Pubitemid 39561611)
18. Devaraj S, Cheung AT, Jialal I, et al.: Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes 2007; 56: 2790-2796. (Pubitemid 350044923)
19. Miyamoto K, Hiroshiba N, Tsujikawa A, Ogura Y: In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. Invest Ophthalmol Vis Sci 1998; 39: 2190-2194. (Pubitemid 28455092)
20. Rajala RV, Wiskur B, Tanito M, Callegan M, Rajala A: Diabetes reduces autophosphorylation of retinal insulin receptor and increases protein-tyrosine phosphatase-1B activity. Invest Ophthalmol Vis Sci 2009; 50: 1033-1040.
21. Aulak KS, Miyagi M, Yan L, et al.: Proteomic method identifies proteins nitrated in vivo during inflammatory challenge. Proc Natl Acad Sci USA 2001; 98: 12056-12061. (Pubitemid 32959825)
22. Sies H: Oxidative stress: from basic research to clinical application: Am J Med 1991; 91:31S-38S.
23. Zheng L, Kern TS: Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. Front Biosci 2009; 14: 3974-3987.
24. Ceriello A: Nitrotyrosine: new findings as a marker of postprandial oxidative stress. Int J Clin Pract 2002; 129: 51-58.
25. Peluffo G, Radi R: Biochemistry of protein tyrosine nitrosylation in cardiovascular pathology. Cardiovasc Res 2007; 75: 291-302. (Pubitemid 46961930)
26. Pacher P, Obrosova IG, Mabley JG, Szabó C: Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 2005; 12: 267-275. (Pubitemid 40305619)
27. Leal EC, Manivannan A, Hosoya K, et al.: Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci 2007; 48: 5257-5265. (Pubitemid 351260939)
28. Du Y, Smith MA, Miller CM, Kern T: Diabetes- induced nitrosative stress in the retina, and correction by aminoguanidine. J Neurochem 2002; 80: 771-779. (Pubitemid 34809229)
29. Sato E, Simpson KL, Grisham MB, Koyama S, Robbins RA: Reactive nitrogen and oxygen species attenuate interleukin-8-induced neutrophil chemotactic activity in vitro. J Biol Chem 2000; 275: 10826-10830. (Pubitemid 30212713)
30. Freels JL, Nelson DK, Hoyt JC, et al.: Enhanced activity of human IL-10 after nitrosylation in reducing human IL-1 production by stimulated peripheral blood mononuclear cells. J Immunol 2002; 169: 4568-4571. (Pubitemid 35178235)
31. Kittipatarin C, Khaled AR: Interlinking interleukin-7. Cytokine 2007; 39: 75-83. (Pubitemid 47446258)
32. Bodaghi B, de Kozak Y, Lehoang P, Rao NA: Editorial. Ophthalmic Res 2008; 40: 113-114.